BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 26021968)

  • 21. TPH-2 Polymorphisms Interact with Early Life Stress to Influence Response to Treatment with Antidepressant Drugs.
    Xu Z; Reynolds GP; Yuan Y; Shi Y; Pu M; Zhang Z
    Int J Neuropsychopharmacol; 2016 Nov; 19(11):. PubMed ID: 27521242
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Novel Augmentation Strategies in Major Depression.
    Martiny K
    Dan Med J; 2017 Apr; 64(4):. PubMed ID: 28385173
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tryptophan hydroxylase 2 gene is associated with major depression and antidepressant treatment response.
    Tsai SJ; Hong CJ; Liou YJ; Yu YW; Chen TJ; Hou SJ; Yen FC
    Prog Neuropsychopharmacol Biol Psychiatry; 2009 Jun; 33(4):637-41. PubMed ID: 19272410
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Harm avoidance as a mediator of treatment response to antidepressant treatment of patients with major depression.
    Quilty LC; Godfrey KM; Kennedy SH; Bagby RM
    Psychother Psychosom; 2010; 79(2):116-22. PubMed ID: 20090398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Trait and state aspects of harm avoidance and its implication for treatment in major depressive disorder, dysthymic disorder, and depressive personality disorder.
    Abrams KY; Yune SK; Kim SJ; Jeon HJ; Han SJ; Hwang J; Sung YH; Lee KJ; Lyoo IK
    Psychiatry Clin Neurosci; 2004 Jun; 58(3):240-8. PubMed ID: 15149288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The FKBP5 polymorphism rs1360780 influences the effect of an algorithm-based antidepressant treatment and is associated with remission in patients with major depression.
    Stamm TJ; Rampp C; Wiethoff K; Stingl J; Mössner R; O Malley G; Ricken R; Seemüller F; Keck M; Fisher R; Gaebel W; Maier W; Möller HJ; Bauer M; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):40-7. PubMed ID: 26645208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of COMT gene polymorphisms on suicidality in treatment resistant major depressive disorder--a European multicenter study.
    Schosser A; Calati R; Serretti A; Massat I; Kocabas NA; Papageorgiou K; Linotte S; Mendlewicz J; Souery D; Zohar J; Juven-Wetzler A; Montgomery S; Kasper S
    Eur Neuropsychopharmacol; 2012 Apr; 22(4):259-66. PubMed ID: 21940152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Orphan nuclear receptor Rev-erb alpha gene (NR1D1) and fluvoxamine response in major depressive disorder in the Japanese population.
    Kishi T; Kitajima T; Ikeda M; Yamanouchi Y; Kinoshita Y; Kawashima K; Okochi T; Ozaki N; Iwata N
    Neuropsychobiology; 2009; 59(4):234-8. PubMed ID: 19571598
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Support for the involvement of the KCNK2 gene in major depressive disorder and response to antidepressant treatment.
    Liou YJ; Chen TJ; Tsai SJ; Yu YW; Cheng CY; Hong CJ
    Pharmacogenet Genomics; 2009 Oct; 19(10):735-41. PubMed ID: 19741570
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NGF gene polymorphisms are not associated with heroin dependence in a Taiwanese male population.
    Tsou CC; Kuo SC; Chen CY; Lu RB; Wang TJ; Huang SY
    Am J Addict; 2018 Sep; 27(6):516-523. PubMed ID: 30070410
    [TBL] [Abstract][Full Text] [Related]  

  • 31. ABCB1 Genetic Effects on Antidepressant Outcomes: A Report From the iSPOT-D Trial.
    Schatzberg AF; DeBattista C; Lazzeroni LC; Etkin A; Murphy GM; Williams LM
    Am J Psychiatry; 2015 Aug; 172(8):751-9. PubMed ID: 25815420
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hippocampal volume predicts antidepressant efficacy in depressed patients without incomplete hippocampal inversion.
    Colle R; Cury C; Chupin M; Deflesselle E; Hardy P; Nasser G; Falissard B; Ducreux D; Colliot O; Corruble E
    Neuroimage Clin; 2016; 12():949-955. PubMed ID: 27995060
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel sequence variations in the brain-derived neurotrophic factor gene and association with major depression and antidepressant treatment response.
    Licinio J; Dong C; Wong ML
    Arch Gen Psychiatry; 2009 May; 66(5):488-97. PubMed ID: 19414708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Influence and interaction of genetic polymorphisms in catecholamine neurotransmitter systems and early life stress on antidepressant drug response.
    Xu Z; Zhang Z; Shi Y; Pu M; Yuan Y; Zhang X; Li L
    J Affect Disord; 2011 Sep; 133(1-2):165-73. PubMed ID: 21680027
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical features and drug induced side effects in early versus late antidepressant responders.
    Fabbri C; Marsano A; Balestri M; De Ronchi D; Serretti A
    J Psychiatr Res; 2013 Oct; 47(10):1309-18. PubMed ID: 23800418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Case-control association study of 14 variants of CREB1, CREBBP and CREM on diagnosis and treatment outcome in major depressive disorder and bipolar disorder.
    Crisafulli C; Shim DS; Andrisano C; Pae CU; Chiesa A; Han C; Patkar AA; Lee SJ; Serretti A; De Ronchi D
    Psychiatry Res; 2012 Jun; 198(1):39-46. PubMed ID: 22386572
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Quantitative electroencephalogram biomarkers for predicting likelihood and speed of achieving sustained remission in major depression: a report from the biomarkers for rapid identification of treatment effectiveness in major depression (BRITE-MD) trial.
    Cook IA; Hunter AM; Gilmer WS; Iosifescu DV; Zisook S; Burgoyne KS; Howland RH; Trivedi MH; Jain R; Greenwald S; Leuchter AF
    J Clin Psychiatry; 2013 Jan; 74(1):51-6. PubMed ID: 23419226
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lack of association of FKBP5 SNPs and haplotypes with susceptibility and treatment response phenotypes in Han Chinese with major depressive disorder: A pilot case-control study (STROBE).
    Yang C; Li S; Ma Y; Chen B; Li M; Bosker FJ; Li J; Nolte IM
    Medicine (Baltimore); 2021 Sep; 100(36):e26983. PubMed ID: 34516490
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of a Single Nucleotide Polymorphism in SIGMAR1 on Depressive Symptoms in Major Depressive Disorder and Bipolar Disorder.
    Mandelli L; Wang SM; Han C; Lee SJ; Patkar AA; Masand PS; Pae CU; Serretti A
    Adv Ther; 2017 Mar; 34(3):713-724. PubMed ID: 28144920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The associations of CNR1 SNPs and haplotypes with vulnerability and treatment response phenotypes in Han Chinese with major depressive disorder: A case-control association study.
    Yang C; Nolte IM; Ma Y; An X; Bosker FJ; Li J
    Mol Genet Genomic Med; 2021 Sep; 9(9):e1752. PubMed ID: 34355541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.